Blood platelets contain tumor-derived RNA biomarkers

R. Jonas A. Nilsson; Leonora Balaj; Esther Hulleman; Sjoerd van Rijn; D. Michiel Pegtel; Maudy Walraven; Anders Widmark; Winald R. Gerritsen; Henk M. Verheul; W. Peter Vandertop; David P. Noske; Johan Skog; Thomas Würdinger

doi:10.1182/blood-2011-03-344408

Blood platelets contain tumor-derived RNA biomarkers

R. Jonas A. Nilsson
, Leonora Balaj
, Esther Hulleman
, Sjoerd van Rijn
, D. Michiel Pegtel
, Maudy Walraven
, Anders Widmark
, Winald R. Gerritsen
, Henk M. Verheul
, W. Peter Vandertop
, David P. Noske
, Johan Skog
, Thomas Würdinger

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Diagnostic platforms providing biomarkers that are highly predictive for diagnosing, monitoring, and stratifying cancer patients are key instruments in the development of personalized medicine. We demonstrate that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and show that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively. In addition, gene-expression profiling revealed a distinct RNA signature in platelets from glioma patients compared with normal control subjects. Because platelets are easily accessible and isolated, they may form an attractive platform for the companion diagnostics of cancer

Original language	English
Pages (from-to)	3680-3683
Journal	Blood
Volume	118
Issue number	13
DOIs	https://doi.org/10.1182/blood-2011-03-344408
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1182/blood-2011-03-344408

Cite this

@article{5792f397b72842a8b38e36d175124a5f,

title = "Blood platelets contain tumor-derived RNA biomarkers",

abstract = "Diagnostic platforms providing biomarkers that are highly predictive for diagnosing, monitoring, and stratifying cancer patients are key instruments in the development of personalized medicine. We demonstrate that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and show that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively. In addition, gene-expression profiling revealed a distinct RNA signature in platelets from glioma patients compared with normal control subjects. Because platelets are easily accessible and isolated, they may form an attractive platform for the companion diagnostics of cancer",

author = "Nilsson, \{R. Jonas A.\} and Leonora Balaj and Esther Hulleman and \{van Rijn\}, Sjoerd and Pegtel, \{D. Michiel\} and Maudy Walraven and Anders Widmark and Gerritsen, \{Winald R.\} and Verheul, \{Henk M.\} and Vandertop, \{W. Peter\} and Noske, \{David P.\} and Johan Skog and Thomas W{\"u}rdinger",

year = "2011",

doi = "10.1182/blood-2011-03-344408",

language = "English",

volume = "118",

pages = "3680--3683",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "13",

}

TY - JOUR

T1 - Blood platelets contain tumor-derived RNA biomarkers

AU - Nilsson, R. Jonas A.

AU - Balaj, Leonora

AU - Hulleman, Esther

AU - van Rijn, Sjoerd

AU - Pegtel, D. Michiel

AU - Walraven, Maudy

AU - Widmark, Anders

AU - Gerritsen, Winald R.

AU - Verheul, Henk M.

AU - Vandertop, W. Peter

AU - Noske, David P.

AU - Skog, Johan

AU - Würdinger, Thomas

PY - 2011

Y1 - 2011

N2 - Diagnostic platforms providing biomarkers that are highly predictive for diagnosing, monitoring, and stratifying cancer patients are key instruments in the development of personalized medicine. We demonstrate that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and show that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively. In addition, gene-expression profiling revealed a distinct RNA signature in platelets from glioma patients compared with normal control subjects. Because platelets are easily accessible and isolated, they may form an attractive platform for the companion diagnostics of cancer

AB - Diagnostic platforms providing biomarkers that are highly predictive for diagnosing, monitoring, and stratifying cancer patients are key instruments in the development of personalized medicine. We demonstrate that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and show that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively. In addition, gene-expression profiling revealed a distinct RNA signature in platelets from glioma patients compared with normal control subjects. Because platelets are easily accessible and isolated, they may form an attractive platform for the companion diagnostics of cancer

U2 - 10.1182/blood-2011-03-344408

DO - 10.1182/blood-2011-03-344408

M3 - Article

C2 - 21832279

SN - 0006-4971

VL - 118

SP - 3680

EP - 3683

JO - Blood

JF - Blood

IS - 13

ER -

Blood platelets contain tumor-derived RNA biomarkers

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this